Skip to main navigation
Horizon Therapeutics plc
Horizon Therapeutics menu
  • Our Company
    • About Us
    • Leadership Team
    • Corporate Social Responsibility
    • Partnering
    • Grant Programs
      • Medical Education
      • External Research
    • Worldwide Locations
    • Contact Us
  • Our Science
    • Research and Development
    • Pipeline
  • Our Medicines
    • Our Portfolio
    • Medicine Support
  • Our Patients
    • Our Commitment
    • Advocacy
      • Overview
      • Resources
    • Disease Information
    • Patient Stories
    • Patient Support
    • Expanded Access
  • Careers
    • Why Horizon
    • Who We Are
    • Benefits
    • Job Opportunities
  • Investors
    • At a Glance
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Governance Overview
      • Whistleblower Hotline
      • Leadership
      • Committee Composition
      • Contact Board
    • Financials & Filings
      • Financial Information
      • SEC Filings
      • GAAP to Non-GAAP Reconciliations
    • Stock Information
      • Stock Quote & Chart
      • Historic Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Annual Reports / Proxy Statements
    • Investors FAQs
    • IR Contact Us
    • IR Email Alerts
  • United States
    • Canada
  • Investors
  • Media Center
  • Follow Us
    • United States
    • Canada

Financial Information

Financial Information

Show all

Latest 10-Q

Filing date Form View
05/09/14 10-Q
0001193125-14-190991.pdf
0001193125-14-190991.rtf
0001193125-14-190991.xls
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Annual Reports

More information is coming soon.

Latest 10-Ks

Filing date Form View
02/28/18 10-K
0001564590-18-003661.pdf
0001564590-18-003661.rtf
0001564590-18-003661.xls
View HTMLEX-101.INS - XBRL INSTANCE DOCUMENT
03/18/13 10-K
0001193125-13-111071.pdf
0001193125-13-111071.rtf
0001193125-13-111071.xls
View HTMLEX-101.INS - XBRL INSTANCE DOCUMENT
02/27/15 10-K
0001193125-15-067257.pdf
0001193125-15-067257.rtf
0001193125-15-067257.xls
View HTMLEX-101.INS - XBRL INSTANCE DOCUMENT
02/26/20 10-K
0001564590-20-006575.pdf
0001564590-20-006575.rtf
0001564590-20-006575.xls
View HTMLEX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Proxy Statements

Filing date Form View
06/02/14 DEF 14A
0001193125-14-221101.pdf
0001193125-14-221101.rtf
0001193125-14-221101.xls
View HTML
04/29/13 DEF 14A
0001193125-13-179602.pdf
0001193125-13-179602.rtf
0001193125-13-179602.xls
View HTML

Investor Relations

  • Investors
  • Press Releases
  • Events & Presentations
  • Corporate Governance
    • Governance Overview
    • Whistleblower Hotline
    • Leadership Team
    • Committee Composition
    • Contact the Board
  • Financial & Filings
    • Financial Information
    • SEC Filings
  • Stock Information
    • Stock Quote & Chart
    • Historic Stock Lookup
    • Investment Calculator
    • Analyst Coverage
  • Annual Reports / Proxy Statements
  • Investor FAQs
  • Contact Us
  • Email Alerts
Investor Contacts Tina Ventura
Senior Vice President,
Investor Relations
Investor-relations@horizontherapeutics.com

Ruth Venning
Executive Director,
Investor Relations
Investor-relations@horizontherapeutics.com
U.S. Media Contact Geoff Curtis
Executive Vice President,
Corporate Affairs & Chief
Communications Officer
media@horizontherapeutics.com
+1 888 506-2562
Ireland Media Contact Ray Gordon
Gordon MRM
ray@gordonmrm.ie
+353 (87) 2417373
Shareholder Tools

Shareholder Tools

  • Email Alerts Subscription
  • RSS News Feeds
  • Snapshot
  • Print
  • Our Company
  • Our Science
  • Our Medicines
  • Our Patients
  • Careers
  • Investors
  • Follow Us
© 2021 Horizon Therapeutics plc
  • Global Privacy Policy
  • Legal Notice
  • Cookie Policy
  • Contact Us

The information provided in this site is intended only for residents of the U.S.

You are leaving horizontherapeutics.com

You are leaving horizontherapeutics.com. You will be redirected to a website operated by an independent third party. This link is provided solely for your convenience.

Continue